Fasiglifam

DRUG3 trials

Sponsors

Takeda

Conditions

Chronic Kidney DiseaseDiabetes Mellitus, Type 2Type 2 Diabetes Mellitus

Phase 2

Fasiglifam 25 mg BID vs 50 mg QD

TerminatedNCT01982253

TakedaType 2 Diabetes Mellitus

Start: 2013-10-31End: 2014-01-31Updated: 2016-10-07

Phase 3

Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

CompletedNCT01456195

TakedaDiabetes Mellitus, Type 2

Start: 2011-11-30End: 2013-07-31Updated: 2016-04-05

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

WithdrawnNCT02015780

TakedaChronic Kidney Disease, Type 2 Diabetes Mellitus

Start: 2013-12-31End: 2016-01-31Updated: 2014-01-27